Correlation Between ReShape Lifesciences and Talis Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ReShape Lifesciences and Talis Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ReShape Lifesciences and Talis Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ReShape Lifesciences and Talis Biomedical Corp, you can compare the effects of market volatilities on ReShape Lifesciences and Talis Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ReShape Lifesciences with a short position of Talis Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of ReShape Lifesciences and Talis Biomedical.

Diversification Opportunities for ReShape Lifesciences and Talis Biomedical

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between ReShape and Talis is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding ReShape Lifesciences and Talis Biomedical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talis Biomedical Corp and ReShape Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ReShape Lifesciences are associated (or correlated) with Talis Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talis Biomedical Corp has no effect on the direction of ReShape Lifesciences i.e., ReShape Lifesciences and Talis Biomedical go up and down completely randomly.

Pair Corralation between ReShape Lifesciences and Talis Biomedical

Given the investment horizon of 90 days ReShape Lifesciences is expected to generate 0.16 times more return on investment than Talis Biomedical. However, ReShape Lifesciences is 6.31 times less risky than Talis Biomedical. It trades about -0.08 of its potential returns per unit of risk. Talis Biomedical Corp is currently generating about -0.63 per unit of risk. If you would invest  932.00  in ReShape Lifesciences on August 29, 2024 and sell it today you would lose (364.00) from holding ReShape Lifesciences or give up 39.06% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy9.52%
ValuesDaily Returns

ReShape Lifesciences  vs.  Talis Biomedical Corp

 Performance 
       Timeline  
ReShape Lifesciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ReShape Lifesciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Talis Biomedical Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Talis Biomedical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

ReShape Lifesciences and Talis Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ReShape Lifesciences and Talis Biomedical

The main advantage of trading using opposite ReShape Lifesciences and Talis Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ReShape Lifesciences position performs unexpectedly, Talis Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talis Biomedical will offset losses from the drop in Talis Biomedical's long position.
The idea behind ReShape Lifesciences and Talis Biomedical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing